{"title":"梅宁抑制剂有望作为白血病最新靶向疗法首次亮相","authors":"Ken Garber","doi":"10.1038/d41573-024-00106-3","DOIUrl":null,"url":null,"abstract":"Small molecules that block a key protein–protein interaction could change the treatment landscape for many patients with acute leukaemias. Small molecules that block a key protein–protein interaction could change the treatment landscape for many patients with acute leukaemias.","PeriodicalId":19068,"journal":{"name":"Nature Reviews. Drug Discovery","volume":"23 8","pages":"567-569"},"PeriodicalIF":101.8000,"publicationDate":"2024-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Menin inhibitors seek to debut as newest targeted therapy for leukaemia\",\"authors\":\"Ken Garber\",\"doi\":\"10.1038/d41573-024-00106-3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Small molecules that block a key protein–protein interaction could change the treatment landscape for many patients with acute leukaemias. Small molecules that block a key protein–protein interaction could change the treatment landscape for many patients with acute leukaemias.\",\"PeriodicalId\":19068,\"journal\":{\"name\":\"Nature Reviews. Drug Discovery\",\"volume\":\"23 8\",\"pages\":\"567-569\"},\"PeriodicalIF\":101.8000,\"publicationDate\":\"2024-06-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nature Reviews. Drug Discovery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.nature.com/articles/d41573-024-00106-3\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Reviews. Drug Discovery","FirstCategoryId":"3","ListUrlMain":"https://www.nature.com/articles/d41573-024-00106-3","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
Menin inhibitors seek to debut as newest targeted therapy for leukaemia
Small molecules that block a key protein–protein interaction could change the treatment landscape for many patients with acute leukaemias. Small molecules that block a key protein–protein interaction could change the treatment landscape for many patients with acute leukaemias.
期刊介绍：
Nature Reviews Drug Discovery is a monthly journal aimed at everyone working in the drug discovery and development arena.
Each issue includes:
Highest-quality reviews and perspectives covering a broad scope.
News stories investigating the hottest topics in drug discovery.
Timely summaries of key primary research papers.
Concise updates on the latest advances in areas such as new drug approvals, patent law, and emerging industry trends and strategies.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
